Traders Buy Walgreens Boots Alliance (WBA) on Weakness

Traders bought shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) on weakness during trading hours on Tuesday. $107.44 million flowed into the stock on the tick-up and $63.92 million flowed out of the stock on the tick-down, for a money net flow of $43.52 million into the stock. Of all stocks tracked, Walgreens Boots Alliance had the 9th highest net in-flow for the day. Walgreens Boots Alliance traded down ($0.25) for the day and closed at $65.97

A number of research analysts recently commented on the company. BidaskClub cut Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a report on Tuesday, April 10th. Jefferies Group set a $85.00 price objective on Walgreens Boots Alliance and gave the company a “buy” rating in a report on Tuesday, April 3rd. Needham & Company LLC reiterated a “buy” rating and issued a $88.00 price objective (up from $86.00) on shares of Walgreens Boots Alliance in a report on Wednesday, January 10th. Royal Bank of Canada set a $88.00 price objective on Walgreens Boots Alliance and gave the company a “buy” rating in a report on Wednesday, March 28th. They noted that the move was a valuation call. Finally, Barclays assumed coverage on Walgreens Boots Alliance in a report on Thursday, March 8th. They issued an “equal weight” rating and a $76.00 price objective on the stock. One analyst has rated the stock with a sell rating, ten have given a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $83.20.

How to Become a New Pot Stock Millionaire

The company has a quick ratio of 0.45, a current ratio of 0.90 and a debt-to-equity ratio of 0.44. The company has a market capitalization of $63,288.10, a P/E ratio of 12.94, a price-to-earnings-growth ratio of 1.03 and a beta of 1.16.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Wednesday, March 28th. The pharmacy operator reported $1.73 EPS for the quarter, topping analysts’ consensus estimates of $1.55 by $0.18. Walgreens Boots Alliance had a return on equity of 20.38% and a net margin of 3.33%. The company had revenue of $33.02 billion for the quarter, compared to analysts’ expectations of $32.20 billion. During the same period in the prior year, the firm earned $1.36 earnings per share. The firm’s revenue was up 12.1% compared to the same quarter last year. research analysts forecast that Walgreens Boots Alliance Inc will post 5.95 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 12th. Shareholders of record on Friday, May 18th will be paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 2.43%. The ex-dividend date is Thursday, May 17th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is 31.37%.

A number of large investors have recently added to or reduced their stakes in the business. Arrowstreet Capital Limited Partnership increased its position in shares of Walgreens Boots Alliance by 675.5% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 5,891,845 shares of the pharmacy operator’s stock worth $427,866,000 after acquiring an additional 5,132,140 shares during the period. LSV Asset Management increased its position in shares of Walgreens Boots Alliance by 38,624.0% during the fourth quarter. LSV Asset Management now owns 3,678,780 shares of the pharmacy operator’s stock worth $267,153,000 after acquiring an additional 3,669,280 shares during the period. Two Sigma Advisers LP increased its position in shares of Walgreens Boots Alliance by 315.6% during the fourth quarter. Two Sigma Advisers LP now owns 2,639,155 shares of the pharmacy operator’s stock worth $191,655,000 after acquiring an additional 2,004,131 shares during the period. CI Global Investments Inc. increased its position in shares of Walgreens Boots Alliance by 32.0% during the fourth quarter. CI Global Investments Inc. now owns 7,373,589 shares of the pharmacy operator’s stock worth $535,470,000 after acquiring an additional 1,785,449 shares during the period. Finally, Amundi Pioneer Asset Management Inc. increased its position in shares of Walgreens Boots Alliance by 875.2% during the fourth quarter. Amundi Pioneer Asset Management Inc. now owns 1,650,553 shares of the pharmacy operator’s stock worth $119,862,000 after acquiring an additional 1,481,305 shares during the period. Institutional investors own 60.90% of the company’s stock.

TRADEMARK VIOLATION WARNING: This piece was originally published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this piece on another site, it was illegally copied and republished in violation of US & international copyright law. The legal version of this piece can be read at https://ledgergazette.com/2018/04/17/traders-buy-walgreens-boots-alliance-wba-on-weakness.html.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply